Halozyme Therapeutics reported $75.91M in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
DBV Technologies DBVT:US USD -38017000 20M
Acadia Pharmaceuticals ACAD:US USD -46063000 15.2M
Agios Pharmaceuticals AGIO:US USD -99172000 8.08M
Alnylam Pharmaceuticals ALNY:US USD -188614000 69.43M
Amarin AMRN:US USD 1.43M 39.05M
Amgen AMGN:US USD 2.23B 436M
Aptinyx Inc APTX:US USD -14657000 2.45M
Baxter International BAX:US USD 312M 209M
Cara Therapeutics CARA:US USD -31307000 7.46M
Cytokinetics CYTK:US USD -127030000 18.59M
Eli Lilly And LLY:US USD 2.11B 169.2M
Esperion Therapeutics ESPR:US USD -42513000 890K
Halozyme Therapeutics HALO:US USD 75.91M 7.78M
Immunogen IMGN:US USD -59559000 17.87M
Intercept Pharmaceuticals ICPT:US USD -17985000 7.84M
Intra Cellular Therapies ITCI:US USD -47412000 8.22M
Intrexon XON:US USD -21797000 14.18M
JAZZ PHA JAZZ:US USD -263386000 462.6M
Mannkind MNKD:US USD -9316000 2.09M
Minerva Neurosciences NERV:US USD -5069730 137.42K
Nektar Therapeutics NKTR:US USD -40889000 3.42M
Peregrine Pharmaceuticals PPHM:US USD 2.72M 5.4M
Pfizer PFE:US USD 5.81B 3.89B
United Therapeutics UTHR:US USD 186.8M 127.5M
Vanda Pharmaceuticals VNDA:US USD 6.63M 2.72M